PROF
Profound Medical Corp
NASDAQ: PROF · HEALTHCARE · MEDICAL DEVICES
$7.22
-0.69% today
Updated 2026-05-06
Market cap
$262.04M
P/E ratio
—
P/S ratio
16.28x
EPS (TTM)
$-1.41
Dividend yield
—
52W range
$4 – $9
Volume
0.2M
Profound Medical Corp (PROF) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $1.47M | $15.27M | $17.63M | $22.17M | $34.18M | $29.89M | $104.60M | $86.66M | $64.42M | $43.96M | $70.23M |
| Cash & equivalents | $1.47M | $7.58M | $15.50M | $8.83M | $22.53M | $14.72M | $83.91M | $67.06M | $46.52M | $26.21M | $54.91M |
| Current assets | $1.47M | $15.08M | $16.72M | $14.00M | $27.84M | $22.68M | $97.74M | $77.02M | $62.02M | $41.90M | $69.06M |
| Total liabilities | $102731.00 | $5.21M | $6.59M | $10.93M | $14.63M | $15.60M | $7.25M | $6.15M | $12.42M | $12.73M | $9.81M |
| Current liabilities | $102731.00 | $913012.00 | $3.68M | $8.53M | $5.79M | $8.18M | $4.81M | $4.15M | $4.18M | $6.37M | $6.57M |
| Long-term debt | — | $5.56M | $3.76M | $443875.00 | $10.62M | $6.72M | — | — | $6.65M | $5.00M | $2.92M |
| Shareholder equity | $1.37M | $10.06M | $11.04M | $11.25M | $19.55M | $14.29M | $97.35M | $80.51M | $52.00M | $31.22M | $60.42M |
| Retained earnings | $-453150.00 | $-39.72M | $-53.16M | $-71.79M | $-81.52M | $-100.34M | $-129.99M | $-160.48M | $-189.36M | $-217.35M | $-245.17M |
| Accounts receivable | $1.38M | $191310.00 | $394565.00 | $3.57M | $2.32M | $3.29M | $7.43M | $1.41M | $6.34M | $7.29M | $7.04M |
| Inventory | $0.00 | $0.00 | $310113.00 | $1.14M | $2.67M | $3.65M | $5.33M | $7.40M | $7.94M | $6.99M | $5.80M |
| Goodwill | — | $0.00 | — | $2.71M | $2.50M | $2.61M | $2.68M | $2.69M | $0.00 | — | — |